The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

por Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., Hattersley, A. T.
Publicado 2012

Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births

por Slingerland, A. S., Shields, B. M., Flanagan, S. E., Bruining, G. J., Noordam, K., Gach, A., Mlynarski, W., Malecki, M. T., Hattersley, A. T., Ellard, S.
Publicado 2009

Urinary C‐peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

por Hope, S. V., Jones, A. G., Goodchild, E., Shepherd, M., Besser, R. E. J., Shields, B., McDonald, T., Knight, B. A., Hattersley, A.
Publicado 2013

Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA(1c) in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical p...

por Marren, S. M., Hammersley, S., McDonald, T. J., Shields, B. M., Knight, B. A., Hill, A., Bolt, R., Tree, T. I., Roep, B. O., Hattersley, A. T., Jones, A. G., Oram, R. A.
Publicado 2019

LB740 SARS-CoV-2-associated ‘covid toes:’ multiplex immunofluorescent characterization of pathophysiology

por Moon, J.J., Costa da Silva, A., Tran, J.M., Kim, C., Sharma, R., Hinshaw, M., Shields, B.E., Brooks, E., Cowen, E.W., Singh, A., Drolet, B., Mays, J., Arkin, L.
Publicado 2021